(Q39418115)

English

A comparative study of two intensified pulse cyclophosphamide remission-inducing regimens for diffuse proliferative lupus nephritis: an Egyptian experience.

scientific article published on 24 January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214709%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

A comparative study of two intensified pulse cyclophosphamide remission-inducing regimens for diffuse proliferative lupus nephritis: an Egyptian experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214709%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

lupus nephritis

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214709%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Alaa Sabry

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214709%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Hamdy Abo-Zenah

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214709%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Tarek Medhat

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214709%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Hussein Sheashaa

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214709%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Amr El-Huseini

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214709%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

24 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214709%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

International Urology and Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214709%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

41

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214709%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214709%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

153-161

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18214709%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis: a preliminary study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The genetics of systemic lupus erythematosus: putting the pieces together

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of lupus nephritis--the advantages of a flexible approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is "aggressive" therapy necessary for systemic lupus erythematosus?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive therapy in lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment for lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful blood pressure control in the African American Study of Kidney Disease and Hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of lupus nephritis: a meta-analysis of clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent intravenous cyclophosphamide therapy for lupus nephritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The very long-term prognosis and complications of lupus nephritis and its treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infectious complications in SLE after immunosuppressive therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lupus nephritis flares

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severity of systemic lupus erythematosus with diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse intravenous cyclophosphamide therapy in Jamaican patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel therapies in lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide: new approaches for systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil for lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18214709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39418115&oldid=1517340482"